Repurposing chlorpromazine to treat COVID-19: The reCoVery study

OBJECTIVES: The ongoing COVID-19 pandemic has caused approximately 2,350,000 infections worldwide and killed more than 160,000 individuals. In Sainte-Anne Hospital (GHU PARIS Psychiatrie & Neuroscience, Paris, France) we have observed a lower incidence of symptomatic forms of COVID-19 among pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Plaze, M., Attali, D., Petit, A.-C., Blatzer, M., Simon-Loriere, E., Vinckier, F., Cachia, A., Chrétien, F., Gaillard, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: L'Encéphale, Paris. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229964/
https://www.ncbi.nlm.nih.gov/pubmed/32425222
http://dx.doi.org/10.1016/j.encep.2020.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229964/
https://www.ncbi.nlm.nih.gov/pubmed/32425222
http://dx.doi.org/10.1016/j.encep.2020.05.006

Ejemplares similares